The past twelve months have culminated in an unprecedented level of excitement, investment, and clinical progress within the gene therapy field. As the field strives to strike a delicate balance ...
CRISPR-based therapies are undergoing a remarkable evolution, with drug developers striving to enhance the safety, precision and efficacy of their products. As this paradigm takes place, more complex ...
The 2nd CRISPR-Based Therapy Analytical Development Summit is returning to Boston this September to unite 50+ key figures across Analytical Development, CMC & QC domains, all with the common goal of ...